The Influence of Pilates Exercises Training Volume on Metabolic Outcomes in Dyslipidemic Women.

October 5, 2017 updated by: Luiz Fernando Martins Kruel, Federal University of Rio Grande do Sul

The Influence of Pilates Exercises Training Volume on Metabolic, Physical Fitness and Quality of Life Outcomes in Dyslipidemic Women: A Controlled Clinical Trial.

The aim of the present study was to assess the influence of different volumes of Pilates training exercises on metabolic, blood pressure (BP), functional physical fitness (PF) and quality of life (QL) outcomes in postmenopausal dyslipidemic women. In total, 26 women participated in the controlled clinical trial, being allocated into three groups: high volume group (HVG; n=9), low volume group (LVG; n=11) and control group (CG, n=6). HVG performed four weekly sessions and LVG performed only twice a week, during 10 weeks with 45 to 55 minutes per session. Before and after the intervention period, metabolic, BP, PF, QL and cardiovascular risk score (CRS) outcomes were measured. The results were described by mean values with lower and upper limits (95% confidence interval). Comparisons between groups and intra-groups were performed adopting Generalized Estimating Equations (GEE) method, with post hoc of Bonferroni and significance level of ɑ=0,05.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Actual)

26

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Brazil
    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil
        • Adriana Cristine Koch Buttelli

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

60 years to 75 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  • Dyslipidemic, postmenopausal and sedentary.

Exclusion Criteria:

  • Women taking statins and smokers.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: High Volume Group
Performed four weekly sessions, during 10 weeks with 45 to 55 minutes per session.
Other: High Volume Group
Performed four weekly session, during 10 weeks with 45 to 55 minutes per session.
Experimental: Low Volume Group
Performed only twice a week, during 10 weeks with 45 to 55 minutes per session.
Other: Low Volume Group
Performed only twice a week, during 10 weeks with 45 to 55 minutes per session.
Placebo Comparator: Control Group
Did not exercise, during 10 weeks.
Other: Control Group
Did not exercise, during 10 weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Metabolic outcomes
Time Frame: 10 weeks
Cholesterol (mg/dl)
10 weeks
Metabolic outcomes
Time Frame: 10 weeks
Low-density lipoprotein (mg/dl)
10 weeks
Metabolic outcomes
Time Frame: 10 weeks
Triglycerides (mg/dl)
10 weeks
Metabolic outcomes
Time Frame: 10 weeks
High-density lipoprotein (mg/dl)
10 weeks
Metabolic outcomes
Time Frame: 10 weeks
TC/HDL ratio
10 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Secondary outcomes
Time Frame: 10 weeks
Systolic blood pressure (mmHg)
10 weeks
Secondary outcomes
Time Frame: 10 weeks
Diastolic blood pressure (mmHg)
10 weeks
Secondary outcomes
Time Frame: 10 weeks
Functional physical fitness
10 weeks
Secondary outcomes
Time Frame: 10 weeks
Quality of life
10 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Federal University of Rio Grande do Sul

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2017

Primary Completion (Actual)

July 28, 2017

Study Completion (Actual)

September 13, 2017

Study Registration Dates

First Submitted

September 13, 2017

First Submitted That Met QC Criteria

October 5, 2017

First Posted (Actual)

October 11, 2017

Study Record Updates

Last Update Posted (Actual)

October 11, 2017

Last Update Submitted That Met QC Criteria

October 5, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 1.990.955

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Dyslipidemias

Clinical Trials on High Volume Group

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe